Clinical Trial Update: Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CLR to fosfomycin trometamol for acute lower urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Urinary Tract Infection
• Urinary Tract Infection

Drugs mentioned

• CLR
• fosfomycin trometamol (fosfomycin trometamol)

Snippet

Sponsor: Bionorica SE | Conditions: Urinary Tract Infection | Phase 3 | Status: COMPLETED